{"id":"https://openalex.org/W1980520140","doi":"https://doi.org/10.1021/jm00129a005","title":"7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity","display_name":"7-Heteroaryl-1,2,3,5-tetrahydroimidazol[2,1-b]quinazolin-2(1H)-one derivatives with cardiac stimulant activity","publication_year":1989,"publication_date":"1989-09-01","ids":{"openalex":"https://openalex.org/W1980520140","doi":"https://doi.org/10.1021/jm00129a005","mag":"1980520140","pmid":"https://pubmed.ncbi.nlm.nih.gov/2769678"},"language":"en","primary_location":{"id":"doi:10.1021/jm00129a005","doi":"https://doi.org/10.1021/jm00129a005","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00129a005","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102839453","display_name":"Andrew Bell","orcid":"https://orcid.org/0000-0002-0581-9387","observed_orcids":["https://orcid.org/0000-0002-0581-9387"]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew S. Bell","raw_affiliation_strings":["Department of Discovery Chemistry, Pfizer Central Research, Sandwich, Kent, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Discovery Chemistry, Pfizer Central Research, Sandwich, Kent, United Kingdom","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109537482","display_name":"Simon F. Campbell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simon F. Campbell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"David A. Roberts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David A. Roberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5024568105","display_name":"Keith S. Ruddock","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Keith S. Ruddock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":0.9807,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.66653562,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"32","issue":"9","first_page":"2042","last_page":"2049"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T12318","display_name":"Quinazolinone synthesis and applications","score":0.9663000106811523,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Synthesis and biological activity","score":0.023000000044703484,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/positive-inotropic-effect","display_name":"positive inotropic effect","score":0.8949999809265137},{"id":"https://openalex.org/keywords/palladium-catalyzed-cross-coupling","display_name":"palladium-catalyzed cross-coupling","score":0.9139999747276306},{"id":"https://openalex.org/keywords/dp-dtmax","display_name":"dP/dtmax","score":0.7599999904632568},{"id":"https://openalex.org/keywords/myocardial-contractility","display_name":"cardiac contractility","score":0.6850000023841858},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.5740000009536743}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9427116513252258},{"id":"https://openalex.org/C2780557958","wikidata":"https://www.wikidata.org/wiki/Q211036","display_name":"Stimulant","level":2,"score":0.7553741335868835},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4057299494743347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.398964524269104},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D002316","descriptor_name":"Cardiotonic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009200","descriptor_name":"Myocardial Contraction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D011799","descriptor_name":"Quinazolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm00129a005","doi":"https://doi.org/10.1021/jm00129a005","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm00129a005","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:2769678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2769678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2086591004","https://openalex.org/W2398216842","https://openalex.org/W1967154893","https://openalex.org/W2319454773","https://openalex.org/W2083261523","https://openalex.org/W2325070150","https://openalex.org/W2312193999","https://openalex.org/W2331789240","https://openalex.org/W2056351671","https://openalex.org/W2952323646"],"abstract_inverted_index":{"A":[0],"series":[1],"of":[2,35,49,92,208,247],"7-heteroaryl-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin++":[3],"+-2":[4],"(1H)-ones":[5],"was":[6,105,175],"synthesized":[7],"and":[8,28,112,125,193,237,245],"evaluated":[9],"in":[10,67,73,75,101,131,151,156,173,215,217],"dogs":[11],"for":[12,177,200,233],"cardiac":[13,152,209,242],"stimulant":[14,243],"activity.":[15],"Compounds":[16],"were":[17,141],"obtained":[18],"by":[19,33],"a":[20,25,29,50,64,84,114],"palladium-catalyzed":[21],"cross-coupling":[22],"reaction":[23],"between":[24],"heteroarylzinc":[26],"chloride":[27],"7-iodo-1,2,3,5-tetrahydroimidazo":[30],"[2,1-b]quinazolin-2(1H)-one":[31,97],"or":[32,55],"cyclization":[34],"an":[36,148,230],"N-[(2-aminophenyl)methyl]glycinate":[37],"with":[38,83],"cyanogen":[39],"bromide.":[40],"Compared":[41],"to":[42,63,251],"the":[43,60,93,168,178,194,202,206,218,226,234],"parent":[44],"ring":[45],"system":[46,236],"(3),":[47],"introduction":[48],"2,6-dimethylpyridin-3-yl":[51],"(6),":[52],"2,4-dimethylimidazol-1-yl":[53],"(7),":[54],"1,2,4-triazol-1-yl":[56],"(8)":[57],"moiety":[58],"at":[59,158],"7-position":[61],"led":[62],"13-17-fold":[65],"increase":[66,72,100,150,155,172,214],"positive":[68,127],"inotropic":[69,128],"activity":[70,129,244],"(percentage":[71],"dP/dtmax)":[74,157,174,216],"anesthetized":[76],"dogs.":[77],"Potency":[78],"could":[79],"be":[80],"further":[81],"enhanced":[82],"9-methyl":[85],"substituent":[86],"(10-12).":[87],"The":[88],"most":[89],"potent":[90],"member":[91],"series,":[94],"7-(2,4-dimethylimidazol-1-yl)-9-methyl-1,2,3,5-tetrahydroimidaz":[95],"o":[96],"(11)":[98],"(23%":[99],"dP/dtmax,":[102],"2":[103],"micrograms/kg),":[104],"80":[106],"times":[107,143],"more":[108,144],"active":[109],"than":[110,205,212],"3":[111],"displayed":[113,197],"5-fold":[115],"advantage":[116],"over":[117],"milrinone.":[118,252],"In":[119,183],"conscious":[120],"dogs,":[121],"6":[122],"elicited":[123],"marked":[124,169],"sustained":[126],"(decrease":[130],"QA":[132],"interval)":[133],"after":[134,165],"oral":[135],"administration":[136],"(1":[137],"mg/kg),":[138],"whereas":[139],"10-12":[140],"10":[142],"potent.":[145],"11":[146,186,239],"produced":[147],"obvious":[149],"contractility":[153],"(20%":[154],"low":[159],"dose":[160],"levels":[161],"(25":[162],"micrograms/kg)":[163],"while,":[164],"100":[166],"micrograms/kg,":[167],"response":[170],"(50%":[171],"maintained":[176],"whole":[179],"7-h":[180],"test":[181],"period.":[182],"these":[184],"experiments,":[185],"had":[187],"no":[188],"effect":[189],"on":[190],"heart":[191],"rate,":[192],"compound":[195],"also":[196],"exceptional":[198],"selectivity":[199],"increasing":[201],"force":[203],"rather":[204],"rate":[207],"contraction":[210],"(greater":[211],"150%":[213],"Starling":[219],"heart-lung":[220],"preparation.":[221],"These":[222],"studies":[223],"demonstrate":[224],"that":[225,238],"tetrahydroimidazoquinazolinone":[227],"nucleus":[228],"is":[229],"effective":[231],"bioisostere":[232],"2(1H)-quinolinone":[235],"displays":[240],"improved":[241],"duration":[246],"action":[248],"when":[249],"compared":[250]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}